Two siblings with CF attending the CF clinic in SVUH are both infected with Burkholderia cenocepacia IIIA. In one host the organism remains confined to the lungs while in the other host, the organism has been isolated both from lungs and blood cultures during exacerbation. Objectives: 1. To investigate whether there are any genetic differences between the sputum isolates from both hosts and between the blood and sputum isolates in the one host. 2. To examine differences in the pathogenicity of these blood and sputum isolates over time in lung epithelial cells, in vitro. Methods: Serial Burkholderia cenocepacia isolates were collected from the two siblings.
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• Restriction Fragment Length Polymorphism (RFLP), pulse field gel electrophoresis (PFGE) and recA sequencing was carried out on all isolates.
• Intracellular invasion of the isolates into CF bronchial epithelial cells (CFBEs) was examined by antibiotic protection assay. Translocation across polarised cell monolayers was also examined.
Conclusions:
• We confirmed the genomovar type of the organism by both RFLP and recA sequencing. All isolates were identical by PFGE typing. RecA sequences did not show any differences. Additional molecular investigations on isolates from both hosts will include analysis of seven house keeping genes by MLST to look for any genetic divergences. (1), N. abscessus (2), N. farcinica (2) and N. cyriacigeorgica (4). Two of the ten patients presented with exacerbations at first recovery. Eight patients were more or less symptomatic with few rales to severe dyspnea, purulent sputum or nodules. In seven out of the 10 samples, Nocardia was associated with other pathogens: Staphylococcus aureus (6 samples), Pseudomonas aeruginosa (3 samples), Stenotrophomonas maltophilia (2 samples), Streptococcus pneumoniae and Haemophilus influenzae (1 sample). Yeasts and molds were also observed. In 8 of the 10 patients, several samples (2 to 5) were Nocardia positive. Cotrimoxazole, b-lactams, aminoglycosides, linezolide, quinolones were used for treatment, systematically or in case of exacerbation, as single agents or in combination and for durations depending on the severity of symptoms.
Conclusion:
The role of Nocardia in CF patients is poorly studied. Our 10 cases confirm that these bacteria can be responsible for asymptomatic and short colonizations, as well as for infections.
